These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14666115)

  • 1. Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.
    Marenco S; Carson RE; Berman KF; Herscovitch P; Weinberger DR
    Neuropsychopharmacology; 2004 Feb; 29(2):259-68. PubMed ID: 14666115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys.
    Tsukada H; Miyasato K; Kakiuchi T; Nishiyama S; Harada N; Domino EF
    Synapse; 2002 Sep; 45(4):207-12. PubMed ID: 12125041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.
    Gallezot JD; Kloczynski T; Weinzimmer D; Labaree D; Zheng MQ; Lim K; Rabiner EA; Ridler K; Pittman B; Huang Y; Carson RE; Morris ED; Cosgrove KP
    Neuropsychopharmacology; 2014 Mar; 39(4):866-74. PubMed ID: 24220025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.
    Ginovart N; Hassoun W; Le Cavorsin M; Veyre L; Le Bars D; Leviel V
    Neuropsychopharmacology; 2002 Jul; 27(1):72-84. PubMed ID: 12062908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.
    Leyton M; Dagher A; Boileau I; Casey K; Baker GB; Diksic M; Gunn R; Young SN; Benkelfat C
    Neuropsychopharmacology; 2004 Feb; 29(2):427-32. PubMed ID: 14583741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
    Hartvig P; Torstenson R; Tedroff J; Watanabe Y; Fasth KJ; Bjurling P; Långström B
    J Neural Transm (Vienna); 1997; 104(4-5):329-39. PubMed ID: 9295169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents.
    Houston GC; Hume SP; Hirani E; Goggi JL; Grasby PM
    Synapse; 2004 Mar; 51(3):206-12. PubMed ID: 14666518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data.
    Kim SE; Han SM
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):833-41. PubMed ID: 19154629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
    Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N; Finnema SJ; Farde L; Gulyás B; Wikström HV; Halldin C; Innis RB
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study.
    Montgomery AJ; Lingford-Hughes AR; Egerton A; Nutt DJ; Grasby PM
    Synapse; 2007 Aug; 61(8):637-45. PubMed ID: 17492764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased binding potential of [(11)C]raclopride during unilateral continuous microinjection of nicotine in rat striatum observed by positron emission tomography.
    Tajima T; Hatano K; Suzuki M; Ogawa M; Sakiyama Y; Kato T; Endo H; Miura H; Matsubara M; Ito K
    Synapse; 2007 Dec; 61(12):943-50. PubMed ID: 17787002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys.
    Tsukada H; Miyasato K; Nishiyama S; Fukumoto D; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Dec; 30(12):2144-53. PubMed ID: 15856080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.